XML 179 R58.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders’ Deficiency (Details) - Schedule of Common Share Option Activity - USD ($)
 6 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
ACI Canada Legacy Performance Options [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of Options , Exercised     (180,000) (2,700,000) (350,000)
Weighted Average Exercise Price, Exercised     $ 0.01 $ 0.01 $ 0.01
Weighted Average Remaining Contractual Life (Years), Exercised    
Number of Options , Options exercisable     6,454,015 6,401,057  
Weighted Average Exercise Price, Options exercisable     $ 0.01 $ 0.01  
Weighted Average Remaining Contractual Life (Years), Options exercisable,     3 years 11 months 15 days 4 years 5 months 19 days  
Aggregate Intrinsic Value, Options exercisable     $ 3,244,272 [1] $ 4,168,787 [2]  
Number of Options, Balance 9,521,057 9,941,057 6,641,057 6,821,057 9,521,057
Weighted Average Exercise Price, Balance $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Weighted Average Remaining Contractual Life (Years), Balance 5 years 10 months 28 days 6 years 8 months 4 days 3 years 11 months 23 days 4 years 6 months 3 days 5 years 10 months 28 days
Aggregate Intrinsic Value, Balance $ 4,609,723 [1],[2] $ 10,645,031 [2] $ 3,338,059 [1] $ 4,441,787 [1],[2] $ 4,609,723 [1],[2]
Stock Option [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of Options, Granted       16,190,000 1,170,000
Weighted Average Exercise Price, Granted       $ 0.16 $ 0.61
Weighted Average Remaining Contractual Life (Years), Granted      
Number of Options, Expired       (772,763) (895,007)
Weighted Average Exercise Price, Expired       $ 0.68 $ 0.97
Weighted Average Remaining Contractual Life (Years), Expired      
Number of Options , Exercised     (272,840) [3] (251,101) [4] (66,519)
Weighted Average Exercise Price, Exercised     $ 0.19 [3] $ 0.17 [4] $ 0.53
Weighted Average Remaining Contractual Life (Years), Exercised     [3] [4]
Number of Options , Options exercisable     11,612,953 8,050,870  
Weighted Average Exercise Price, Options exercisable     $ 0.18 $ 0.18  
Weighted Average Remaining Contractual Life (Years), Options exercisable,     8 years 4 months 6 days 9 years 25 days  
Aggregate Intrinsic Value, Options exercisable     $ 3,874,616 [5] $ 3,815,397 [6]  
Number of Options, Balance 5,506,071 5,297,597 20,399,367 20,672,207 5,506,071
Weighted Average Exercise Price, Balance $ 0.61 $ 0.81 $ 0.17 $ 0.18 $ 0.61
Weighted Average Remaining Contractual Life (Years), Balance 8 years 5 months 19 days 9 years 2 months 19 days 8 years 6 months 29 days 9 years 25 days 8 years 5 months 19 days
Aggregate Intrinsic Value, Balance [5],[6] $ 1,472,041 [6] $ 6,939,458 [5] $ 9,975,524 [5],[6] [5],[6]
[1] The aggregate intrinsic values were calculated as the difference between the exercise price of the options and the closing price of the Company’s common share. The calculation excludes options with an exercise price higher than the closing price of the Company’s shares on the reporting date
[2] The aggregate intrinsic values were calculated as the difference between the exercise price of the options and the closing price of the Company’s common share on December 31, 2023 and 2022. The calculation excludes options with an exercise price higher than the closing price of the Company’s share on December 31, 2023, and 2022.
[3] In accordance with the Company’s 2023 Option Plan, option holders exercised 272,840 Common Share options on a cashless basis (net exercise) for the issuance of 192,500 Common Shares.
[4] In accordance with the Company’s 2023 Option Plan, option holders exercised 251,101 Common Share options on a cashless basis (net exercise) for the issuance of 165,000 Common Shares.
[5] The aggregate intrinsic values were calculated as the difference between the exercise price of the options and the closing price of the Company’s common share. The calculation excludes options with an exercise price higher than the closing price of the Company’s share on the reporting date.
[6] The aggregate intrinsic values were calculated as the difference between the exercise price of the options and the closing price of the Company’s common share on December 31, 2023, and 2022. The calculation excludes options with an exercise price higher than the closing price of the Company’s share on December 31, 2023 and 2022.